Institutional members access full text with Ovid®

Share this article on:

CHOROIDAL STRUCTURAL CHANGES AND VASCULARITY INDEX IN STARGARDT DISEASE ON SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY

Ratra, Dhanashree, MS*; Tan, Roy, MMed; Jaishankar, Durgasri, BSc*; Khandelwal, Neha, MS; Gupta, Arushi, DOMS; Chhablani, Jay, MS; Agrawal, Rupesh, MD*,§

doi: 10.1097/IAE.0000000000001879
Original Study: PDF Only

Purpose: To evaluate structural changes in the choroid of patients with Stargardt disease using swept source optical coherence tomography scans.

Methods: A retrospective comparison cohort study was conducted on 39 patients with Stargardt disease, and on 25 age and gender matched-healthy controls. Subfoveal choroidal thickness (SFCT) was computed from the swept source optical coherence tomography machine, and the scans were binarized into luminal area and stromal areas, which were then used to derive choroidal vascularity index (CVI). Choroidal vascularity index and SFCT were analyzed independently using linear mixed effects model.

Results: There was no significant difference in SFCT between the 2 groups (347.20 ± 13.61 μm in Stargardt disease vs. 333.09 ± 18.96 μm in the control group, P = 0.548). There was a significant decrease in the CVI among eyes with Stargardt disease as compared with the normal eyes (62.51 ± 0.25% vs. 65.45 ± 0.29%, P < 0.001). There was a negative association between visual acuity and CVI (correlation coefficient = −0.75, P < 0.001) and a positive association between visual acuity and SFCT (correlation coefficient = 0.21, P = 0.035).

Conclusion: Choroidal vascularity index appears to be a more robust tool compared with SFCT for choroidal changes in Stargardt disease. Choroidal vascularity index can possibly be used as a surrogate marker for disease monitoring. A decrease in CVI was associated with a decrease in visual function in eyes with Stargardt disease.

Choroidal vascularity index can provide novel insight into structural changes in the choroid in patients with Stargardt disease.

*Department of Ophthalmology, Medical Research Foundation, Sankara Netralya, Chennai, India;

Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Novena, Singapore;

Smt Kanuri Santhamma Centre for Vitreoretinal Diseases, L. V. Prasad Eye Institute, Hyderabad, India; and

§School of Material Science and Engineering, Nanyang Technological University, Novena, Singapore.

Reprint requests: Rupesh Agrawal, MD. Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore 308433; e-mail: rupesh_agrawal@ttsh.com.sg

None of the authors has any financial/conflicting interests to disclose.

D. Ratra and R. Tan are the joint first authors.

© 2018 by Ophthalmic Communications Society, Inc.